These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33022533)

  • 1. Modeling of osteosarcoma with induced pluripotent stem cells.
    Pang LK; Pena M; Zhao R; Lee DF
    Stem Cell Res; 2020 Dec; 49():102006. PubMed ID: 33022533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells.
    Zhou R; Xu A; Tu J; Liu M; Gingold JA; Zhao R; Lee DF
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.
    Lin YH; Jewell BE; Gingold J; Lu L; Zhao R; Wang LL; Lee DF
    Trends Mol Med; 2017 Aug; 23(8):737-755. PubMed ID: 28735817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism.
    Kim H; Yoo S; Zhou R; Xu A; Bernitz JM; Yuan Y; Gomes AM; Daniel MG; Su J; Demicco EG; Zhu J; Moore KA; Lee DF; Lemischka IR; Schaniel C
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11128-E11137. PubMed ID: 30385632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.
    Zhou R; Xu A; Gingold J; Strong LC; Zhao R; Lee DF
    Trends Pharmacol Sci; 2017 Oct; 38(10):908-927. PubMed ID: 28818333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.
    Ribi S; Baumhoer D; Lee K; Edison ; Teo AS; Madan B; Zhang K; Kohlmann WK; Yao F; Lee WH; Hoi Q; Cai S; Woo XY; Tan P; Jundt G; Smida J; Nathrath M; Sung WK; Schiffman JD; Virshup DM; Hillmer AM
    Oncotarget; 2015 Apr; 6(10):7727-40. PubMed ID: 25762628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling familial cancer with induced pluripotent stem cells.
    Lee DF; Su J; Kim HS; Chang B; Papatsenko D; Zhao R; Yuan Y; Gingold J; Xia W; Darr H; Mirzayans R; Hung MC; Schaniel C; Lemischka IR
    Cell; 2015 Apr; 161(2):240-54. PubMed ID: 25860607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of two induced pluripotent stem cell lines from patients with Li-Fraumeni Syndrome carrying TP53 mutation.
    Sun J; Ren L; Canel Rivero G; Xu L; Ladabaum U; C Wu J
    Stem Cell Res; 2024 Aug; 81():103527. PubMed ID: 39133963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline TP53 variants and susceptibility to osteosarcoma.
    Mirabello L; Yeager M; Mai PL; Gastier-Foster JM; Gorlick R; Khanna C; Patiño-Garcia A; Sierrasesúmaga L; Lecanda F; Andrulis IL; Wunder JS; Gokgoz N; Barkauskas DA; Zhang X; Vogt A; Jones K; Boland JF; Chanock SJ; Savage SA
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25896519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.
    Piao J; Sakurai N; Iwamoto S; Nishioka J; Nakatani K; Komada Y; Mizutani S; Takagi M
    Mol Carcinog; 2013 Oct; 52(10):770-6. PubMed ID: 22495821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
    Kumamoto T; Yamazaki F; Nakano Y; Tamura C; Tashiro S; Hattori H; Nakagawara A; Tsunematsu Y
    Int J Clin Oncol; 2021 Dec; 26(12):2161-2178. PubMed ID: 34633580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel p53 splicing site mutation in Li-Fraumeni-like syndrome with osteosarcoma.
    Sakurai N; Iwamoto S; Miura Y; Nakamura T; Matsumine A; Nishioka J; Nakatani K; Komada Y
    Pediatr Int; 2013 Feb; 55(1):107-11. PubMed ID: 23409989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling.
    Zhu D; Kong CSL; Gingold JA; Zhao R; Lee DF
    Adv Exp Med Biol; 2018; 1119():169-183. PubMed ID: 30069853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Li-Fraumeni Syndrome-Current Status and Prospects in Clinical Practice].
    Hattori H
    Gan To Kagaku Ryoho; 2019 Jul; 46(7):1103-1108. PubMed ID: 31296811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Li-Fraumeni syndrome in pediatric patients with soft tissue sarcoma or osteosarcoma.
    Carnevale A; Lieberman E; Cárdenas R
    Arch Med Res; 1997; 28(3):383-6. PubMed ID: 9291635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA H19 Suppresses Osteosarcomagenesis by Regulating snoRNAs and DNA Repair Protein Complexes.
    Xu A; Huang MF; Zhu D; Gingold JA; Bazer DA; Chang B; Wang D; Lai CC; Lemischka IR; Zhao R; Lee DF
    Front Genet; 2020; 11():611823. PubMed ID: 33519915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Li-Fraumeni syndrome in Tunisian carriers with different and rare tumor phenotype: genotype-phenotype correlation.
    Sassi H; Meddeb R; Cherif MA; Nasr C; Riahi A; Hannachi S; Belguith N; M'rad R
    BMC Med Genomics; 2022 Mar; 15(1):44. PubMed ID: 35246108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
    Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
    Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric oncologist willingness to offer germline TP53 testing in osteosarcoma.
    Shaul E; Roth M; Lo Y; Geller DS; Hoang B; Yang R; Malkin D; Gorlick R; Gill J
    Cancer; 2018 Mar; 124(6):1242-1250. PubMed ID: 29313943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.